Protecting workers and the surrounding environment from exposure to hazardous compounds poses an increasing challenge to pharmaceutical manufacturers as new and more potent active pharmaceutical ingredients (APIs) enter the processing pipeline, such as cytotoxic drugs to treat cancer.
Separation and purification processes potentially expose workers to harmful, biologically active, contaminating particulates and cataylysts filtered from the APIs. To help remedy the problem, Pall is introducing the GBK Containment System which provides the pharmaceutical industry with an all-in-one contained glove bag/housing system for filter change-out.
AlphaThera oYo-Link Antibody Labeling Reagents
AlphaThera's oYo-Link Antibody Labeling Reagents enable site-specific antibody labelling....
Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers
The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...
RevMAb Biosciences histone family protein monoclonal antibodies
RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...
